Considering this information, we reconstructed the CLL subnetwork of the analyzed transcriptionally regulated nodes (Fig. 5A) and found that, according to our model, TP53 strongly inhibits transcriptional activation of MYC, which itself further activates CITED2 and BMI1 on a transcriptional level. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.